Agilent Technologies Inc vs MGM Resorts International — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while MGM Resorts International trades at $43.5 (market cap $10.91B). The key difference: Agilent Technologies Inc is far larger — about 3.8× MGM Resorts International's market cap, and Agilent Technologies Inc pays the higher dividend (0.69%). Which is the better fit depends on your goals.
| A | MGM | |
|---|---|---|
Market Cap | $42.00B | $10.91B |
Sector | Health | Consumer Cyclical |
52-Week High | $157.20 | $50.69 |
52-Week Low | $110.24 | $30.72 |
Enterprise Value | $43.55B | $38.21B |
Dividend Yield | 0.69% | 0.03% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
MGM Resorts International (MGM) trades at $44.47, down 0.51% on the day, with a bearish technical signal and neutral oscillators. The company reported record Q2 2026 revenue but missed earnings estimates, with net income margin at 2.4% and ROE at 15.44%. Recent news includes a potential acquisition investigation and BetMGM's expansion in Canada, while cash flow trends show improving net cash flow projections for 2026.
Outlook is mixed: analyst consensus leans neutral with a $51.14 price target, but risks include regulatory scrutiny and competitive pressures. The stock offers value with a P/S of 0.66, but investors should weigh earnings volatility and debt levels against growth in digital and Las Vegas operations.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.
Read more on MGM →